Midlife Vascular Risk Factors and Alzheimer's Disease: Evidence from Epidemiological Studies

被引:100
作者
Tolppanen, Anna-Maija [1 ]
Solomon, Alina [2 ]
Soininen, Hilkka [3 ]
Kivipelto, Miia [2 ]
机构
[1] Univ Eastern Finland, Sch Med, Inst Clin Med Neurol, FIN-70211 Kuopio, Finland
[2] Karolinska Inst, Aging Res Ctr, Stockholm, Sweden
[3] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland
基金
芬兰科学院;
关键词
Alzheimer's disease; blood pressure; cholesterol; diabetes mellitus; epidemiology; metabolic syndrome X; obesity; risk factors; stroke; vascular diseases; APOLIPOPROTEIN-E EPSILON-4; BLOOD-PRESSURE; COGNITIVE FUNCTION; METABOLIC SYNDROME; ATRIAL-FIBRILLATION; LATE-LIFE; CARDIOVASCULAR RISK; INCIDENT DEMENTIA; TOTAL CHOLESTEROL; CAROTID ATHEROSCLEROSIS;
D O I
10.3233/JAD-2012-120802
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The shared risk factor profile between cardiovascular diseases and Alzheimer's disease (AD), observations on vascular pathology in AD, and altered cerebral blood flow in AD brains have led to the suggestion that AD might be a vascular disorder with neurodegenerative consequences. Targeting vascular and metabolic risk factors could be an effective way to prevent AD. Higher body mass index, elevated blood pressure, serum cholesterol concentrations, and impaired glucose regulation have been associated with increased risk of AD. Interestingly, the associations between these factors measured at mid-life are stronger, or even opposite, than with the risk factors measured at late-life. This may reflect true differences in the association (i.e., mid-life risk factors being a better measure of vascular load during adulthood), reverse causality, or bias. The vascular risk factors can directly increase the susceptibility to AD, or the effect can be mediated via cardio-and cerebrovascular diseases.
引用
收藏
页码:531 / 540
页数:10
相关论文
共 112 条
[1]  
[Anonymous], 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003804
[2]  
[Anonymous], EVIDENCE REPORTS TEC
[3]   Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies [J].
Anstey, K. J. ;
Cherbuin, N. ;
Budge, M. ;
Young, J. .
OBESITY REVIEWS, 2011, 12 (501) :e426-e437
[4]   Cholesterol as a risk factor for dementia and cognitive decline: A systematic review of prospective studies with meta-analysis [J].
Anstey, Kaarin J. ;
Lipnicki, Darren M. ;
Low, Lee-Fay .
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2008, 16 (05) :343-354
[5]   Mechanisms of coronary microvascular adaptation to obesity [J].
Bagi, Zsolt .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2009, 297 (03) :R556-R567
[6]   The projected effect of risk factor reduction on Alzheimer's disease prevalence [J].
Barnes, Deborah E. ;
Yaffe, Kristine .
LANCET NEUROLOGY, 2011, 10 (09) :819-828
[7]   Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers [J].
Beeri, MS ;
Rapp, M ;
Silverman, JM ;
Schmeidler, J ;
Grossman, HT ;
Fallon, JT ;
Purohit, DP ;
Perl, DP ;
Siddiqui, A ;
Lesser, G ;
Rosendorff, C ;
Haroutunian, V .
NEUROLOGY, 2006, 66 (09) :1399-1404
[8]   Statins and cognitive function in the elderly - The Cardiovascular Health Study [J].
Bernick, C ;
Katz, R ;
Smith, NL ;
Rapp, S ;
Bhadelia, R ;
Carlson, M ;
Kuller, L .
NEUROLOGY, 2005, 65 (09) :1388-1394
[9]   Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis [J].
Beydoun, M. A. ;
Beydoun, H. A. ;
Wang, Y. .
OBESITY REVIEWS, 2008, 9 (03) :204-218
[10]  
Bos Daniel, 2012, Alzheimers Dement, V8, pS104, DOI 10.1016/j.jalz.2012.01.008